Payment overview · 2025
General Payments
$2,759.43
88 reported records · 21 companies
Healthcare provider profile · identity verified
Larry Horesh, M.D.
Allopathic & Osteopathic Physicians|Radiology|Vascular & Interventional Radiology · SAVANNAH, GA · NPI 1154398709
Verified facts
What the public records show
CMS Open Payments records show Larry Horesh, M.D. received $2,759.43 in general payments during 2025 across 88 reported records.
Stryker Corporation accounted for 24.4% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 33 associated products.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Stryker Corporation | Unresolved — no canonical attribution shown | $671.92 | 24.4% | 26 | 2025 |
| Endologix LLC | Unresolved — no canonical attribution shown | $340.98 | 12.4% | 7 | 2025 |
| AngioDynamics, Inc. | Unresolved — no canonical attribution shown | $337.12 | 12.2% | 17 | 2025 |
| Imperative Care, Inc | Unresolved — no canonical attribution shown | $308.65 | 11.2% | 5 | 2025 |
| W. L. Gore & Associates, Inc. | Unresolved — no canonical attribution shown | $246.64 | 8.9% | 5 | 2025 |
| Shockwave Medical, Inc | Unresolved — no canonical attribution shown | $190.50 | 6.9% | 7 | 2025 |
| Medtronic, Inc. |
Medtronic, Inc. exact · evidence 2025-07-22 |
$170.33 | 6.2% | 1 | 2025 |
| DePuy Synthes Sales Inc. | Unresolved — no canonical attribution shown | $116.10 | 4.2% | 1 | 2025 |
| Organogenesis Inc. | Unresolved — no canonical attribution shown | $74.64 | 2.7% | 3 | 2025 |
| Abbott Laboratories | Unresolved — no canonical attribution shown | $53.63 | 1.9% | 3 | 2025 |
| Flowphysix Inc | Unresolved — no canonical attribution shown | $37.65 | 1.4% | 1 | 2025 |
| Bard Peripheral Vascular, Inc. | Unresolved — no canonical attribution shown | $29.73 | 1.1% | 1 | 2025 |
| ABIOMED | Unresolved — no canonical attribution shown | $28.89 | 1.1% | 1 | 2025 |
| InspireMD Ltd | Unresolved — no canonical attribution shown | $26.01 | 0.9% | 1 | 2025 |
| Cook Medical LLC | Unresolved — no canonical attribution shown | $23.31 | 0.8% | 3 | 2025 |
| Terumo Medical Corporation | Unresolved — no canonical attribution shown | $19.44 | 0.7% | 1 | 2025 |
| Route 92 Medical, Inc. | Unresolved — no canonical attribution shown | $18.71 | 0.7% | 1 | 2025 |
| Boston Scientific Corporation | Unresolved — no canonical attribution shown | $18.20 | 0.7% | 1 | 2025 |
| Inari Medical, Inc. | Unresolved — no canonical attribution shown | $17.53 | 0.6% | 1 | 2025 |
| TriSalus Life Sciences, Inc. | Unresolved — no canonical attribution shown | $17.32 | 0.6% | 1 | 2025 |
| Reflow Medical Inc | Unresolved — no canonical attribution shown | $12.13 | 0.4% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $2,759.43 | 88 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| ARTIX MT Normalized: artix mt |
Device | Stryker Corporation | $400.80 | 15 | 2025 |
Source payment records
|
|||||
| AURYON LASER SYSTEM 100-120 VAC Normalized: auryon laser system 100 120 vac |
Device | AngioDynamics, Inc. | $337.12 | 17 | 2025 |
Source payment records
|
|||||
| Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter Normalized: shockwave ivl system with the shockwave c2 coronary ivl catheter |
Device | Shockwave Medical, Inc | $190.50 | 7 | 2025 |
Source payment records
|
|||||
| AFX2 Bifurcated Endograft System Normalized: afx2 bifurcated endograft system |
Device | Endologix LLC | $182.50 | 6 | 2025 |
Source payment records
|
|||||
| Ovation iX Iliac Stent Graft Normalized: ovation ix iliac stent graft |
Device | Endologix LLC | $182.50 | 6 | 2025 |
Source payment records
|
|||||
| VALIANT CAPTIVIA Normalized: valiant captivia |
Device | Medtronic, Inc. | $170.33 | 1 | 2025 |
Source payment records
|
|||||
| ZOOM 88-T LARGE DISTAL PLATFORM Normalized: zoom 88 t large distal platform |
Device | Imperative Care, Inc | $168.80 | 2 | 2025 |
Source payment records
|
|||||
| Alto Abdominal Stent Graft System Normalized: alto abdominal stent graft system |
Device | Endologix LLC | $158.48 | 1 | 2025 |
Source payment records
|
|||||
| GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis Normalized: gore excluder thoracoabdominal branch endoprosthesis |
Device | W. L. Gore & Associates, Inc. | $147.32 | 4 | 2025 |
Source payment records
|
|||||
| CEREPAK UNIFORM Normalized: cerepak uniform |
Device | DePuy Synthes Sales Inc. | $116.10 | 1 | 2025 |
Source payment records
|
|||||
| GORE VIABAHN Endoprosthesis with Heparin Normalized: gore viabahn endoprosthesis with heparin |
Device | W. L. Gore & Associates, Inc. | $99.32 | 1 | 2025 |
Source payment records
|
|||||
| CLOTTRIEVER BOLD CATHETER Normalized: clottriever bold catheter |
Device | Stryker Corporation | $95.97 | 3 | 2025 |
Source payment records
|
|||||
| CT THROMBECTOMY SYSTEM KIT Normalized: ct thrombectomy system kit |
Device | Inari Medical, Inc., Stryker Corporation | $85.11 | 4 | 2025 |
Source payment records
|
|||||
| FLOWTRIEVER CATHETER, S Normalized: flowtriever catheter s |
Device | Inari Medical, Inc., Stryker Corporation | $85.11 | 4 | 2025 |
Source payment records
|
|||||
| ZOOM 7X CATHETER Normalized: zoom 7x catheter |
Device | Imperative Care, Inc | $83.95 | 1 | 2025 |
Source payment records
|
|||||
| ESPRIT Normalized: esprit |
Device | Abbott Laboratories | $53.63 | 3 | 2025 |
Source payment records
|
|||||
| PURAPLY WOUND MATRIX Normalized: puraply wound matrix |
Device | Organogenesis Inc. | $46.60 | 2 | 2025 |
Source payment records
|
|||||
| VENACORE THROMBECTOMY CATHETER Normalized: venacore thrombectomy catheter |
Device | Stryker Corporation | $39.26 | 1 | 2025 |
Source payment records
|
|||||
| ZOOM CATHETER Normalized: zoom catheter |
Device | Imperative Care, Inc | $39.05 | 1 | 2025 |
Source payment records
|
|||||
| FLOWRUNNER Normalized: flowrunner |
Device | Flowphysix Inc | $37.65 | 1 | 2025 |
Source payment records
|
|||||
| BROADWAY 8 Normalized: broadway 8 |
Device | Stryker Corporation | $35.15 | 2 | 2025 |
Source payment records
|
|||||
| FLOWTRIEVER Normalized: flowtriever |
Device | Stryker Corporation | $33.16 | 2 | 2025 |
Source payment records
|
|||||
| Venovo Normalized: venovo |
Device | Bard Peripheral Vascular, Inc. | $29.73 | 1 | 2025 |
Source payment records
|
|||||
| APLIGRAF Normalized: apligraf |
Device | Organogenesis Inc. | $28.04 | 1 | 2025 |
Source payment records
|
|||||
| CGuard Prime Carotid Stent System Normalized: cguard prime carotid stent system |
Device | InspireMD Ltd | $26.01 | 1 | 2025 |
Source payment records
|
|||||
| AZUR CX DETACHABLE Normalized: azur cx detachable |
Device | Terumo Medical Corporation | $19.44 | 1 | 2025 |
Source payment records
|
|||||
| PROGREAT Normalized: progreat |
Device | Terumo Medical Corporation | $19.44 | 1 | 2025 |
Source payment records
|
|||||
| myLUX Patient Kit with mobile device Normalized: mylux patient kit with mobile device |
Device | Boston Scientific Corporation | $18.20 | 1 | 2025 |
Source payment records
|
|||||
| TRINAV INFUSION SYSTEM Normalized: trinav infusion system |
Device | TriSalus Life Sciences, Inc. | $17.32 | 1 | 2025 |
Source payment records
|
|||||
| PRODIGY CATHETER Normalized: prodigy catheter |
Device | Imperative Care, Inc | $16.85 | 1 | 2025 |
Source payment records
|
|||||
| ZILVER PTX Normalized: zilver ptx |
Device | Cook Medical LLC | $13.44 | 1 | 2025 |
Source payment records
|
|||||
| ICAST COVERED STENT SYSTEM, 6MMX22MMX120CM Normalized: icast covered stent system 6mmx22mmx120cm |
Device | Cook Medical LLC | $6.97 | 1 | 2025 |
Source payment records
|
|||||
| TORCON NB Normalized: torcon nb |
Device | Cook Medical LLC | $2.90 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Eliquis | Apixaban | 335 | 78 |
| Clopidogrel | Clopidogrel Bisulfate | 301 | 111 |
| Xarelto | Rivaroxaban | 119 | 28 |
| Furosemide | Furosemide | 67 | 26 |
| Potassium Chloride | Potassium Chloride | 66 | 30 |
| Cilostazol | Cilostazol | 59 | 19 |
| Atorvastatin Calcium | Atorvastatin Calcium | 56 | 27 |
| Pregabalin | Pregabalin | 39 | suppressed |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 38 | 11 |
| Amlodipine Besylate | Amlodipine Besylate | 37 | 11 |
| Lactulose | Lactulose | 34 | suppressed |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 30 | 18 |
| Gabapentin | Gabapentin | 27 | 11 |
| Tramadol Hcl | Tramadol Hcl | 20 | 15 |
| Enoxaparin Sodium | Enoxaparin Sodium | 16 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 16 | suppressed |
| Bumetanide | Bumetanide | 13 | suppressed |
| Carvedilol | Carvedilol | 13 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 12 | suppressed |
| Prednisone | Prednisone | 12 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $2,759.43 · 88 records | Stryker Corporation | AFX2 Bifurcated Endograft System, APLIGRAF, ARTIX MT, AURYON LASER SYSTEM 100-120 VAC, AZUR CX DETACHABLE, Alto Abdominal Stent Graft System, BROADWAY 8, CEREPAK UNIFORM, CGuard Prime Carotid Stent System, CLOTTRIEVER BOLD CATHETER, CT THROMBECTOMY SYSTEM KIT, ESPRIT, FLOWRUNNER, FLOWTRIEVER, FLOWTRIEVER CATHETER, S, GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis, GORE VIABAHN Endoprosthesis with Heparin, ICAST COVERED STENT SYSTEM, 6MMX22MMX120CM, Ovation iX Iliac Stent Graft, PRODIGY CATHETER, PROGREAT, PURAPLY WOUND MATRIX, Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter, TORCON NB, TRINAV INFUSION SYSTEM, VALIANT CAPTIVIA, VENACORE THROMBECTOMY CATHETER, Venovo, ZILVER PTX, ZOOM 7X CATHETER, ZOOM 88-T LARGE DISTAL PLATFORM, ZOOM CATHETER, myLUX Patient Kit with mobile device | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error